Back to top
more

Colfax Corporation (CFX)

(Delayed Data from NYSE)

$33.31 USD

33.31
962,229

+1.68 (5.31%)

Updated Aug 7, 2020 04:00 PM ET

3-Hold of 5     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.33%
2Buy17.77%
3Hold9.37%
4Sell4.88%
5Strong Sell1.79%
S&P50010.56%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

C Value C Growth F Momentum D VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Zacks News

Zacks Equity Research

Colfax (CFX) Tops Q2 Earnings Estimates, Gives Impressive View

Colfax's (CFX) Q2 results reflect the adverse impacts of the pandemic on product demand and forex woes. It predicts generating sequentially higher profits and positive cash flow in Q3.

Zacks Equity Research

Colfax (CFX) Beats Q2 Earnings and Revenue Estimates

Colfax (CFX) delivered earnings and revenue surprises of 50.00% and 2.91%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Analysts Estimate Colfax (CFX) to Report a Decline in Earnings: What to Look Out for

Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Cintas (CTAS) to Report Q4 Earnings: What's in the Offing?

Cintas' (CTAS) fiscal Q4 performance is expected to have gained from an expanded product portfolio and the G&K Services buyout despite the pandemic-led market downturn.

Zacks Equity Research

Allegion (ALLE) to Post Q2 Earnings: Is a Beat in the Cards?

Allegion's (ALLE) Q2 earnings are expected to have gained from strength in residential and non-residential businesses. The pandemic-led market downturn and forex woes might have been dragging.

Zacks Equity Research

Colfax (CFX) Shares Gain 41% in 3 Months: What's Driving It?

Colfax (CFX), with 41% growth in shares in the past three months, benefits from the overall revival in the broader market, buyout impacts, solid product offerings and cost-saving measures.

Zacks Equity Research

Can Colfax (CFX) Keep the Earnings Surprise Streak Alive?

Colfax (CFX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

Xylem (XYL) Provides Update on Q2 results, Confirms Deal Wins

Xylem (XYL) provides a financial update for second-quarter results. Also, it secures two significant contracts in the second quarter.

Zacks Equity Research

Alcoa's (AA) Unit Closes $750M Worth Senior Notes Offering

Alcoa's (AA) subsidiary closes the offering of $750 million worth of senior notes. The proceeds will be used for boosting its cash balance and satisfying corporate purposes.

Zacks Equity Research

Here's Why You Should Consider Buying Altra Industrial (AIMC)

Altra Industrial (AIMC) gains from its solid product portfolio, strength across factory automation and medical end markets, robust liquidity position, and cost-management initiatives.

Zacks Equity Research

Enerpac's Products & Cost-Saving Moves to Aid Amid Pandemic

Enerpac's (EPAC) efforts to introduce new products as well as its cost-savings actions are likely to aid, especially in the present uncertainties caused by the coronavirus outbreak.

Zacks Equity Research

Why Is Colfax (CFX) Up 22.4% Since Last Earnings Report?

Colfax (CFX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Colfax (CFX) Declines 23% YTD: What's Hurting the Stock?

Colfax (CFX), with a 23% decline in shares so far in 2020, faces the adverse impacts of the pandemic. High debts and forex woes are other concerns. However, cost-reduction actions might aid.

Zacks Equity Research

Colfax (CFX) Beats Q1 Earnings Estimates, Withdraws View

Colfax's (CFX) Q1 results reflect the adverse impacts of the pandemic and contributions from the DJO Global buyout. It withdraws projections for 2020, while expects demand to be the lowest in the second quarter.

Zacks Equity Research

Colfax (CFX) Beats Q1 Earnings and Revenue Estimates

Colfax (CFX) delivered earnings and revenue surprises of 2.70% and 3.05%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Industrial Stocks' May 7 Earnings Roster: BLL, AAXN & More

A peak at how some industrials are expected to fare this earnings season amid the coronavirus impact.

Zacks Equity Research

Earnings Preview: Colfax (CFX) Q1 Earnings Expected to Decline

Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Colfax (CFX) Surges: Stock Moves 6.1% Higher

Colfax (CFX) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Zacks Equity Research

Colfax (CFX) Displays Bright Prospects, Headwinds Remain

Colfax (CFX) is likely to benefit from its focus on strengthening segmental businesses, productivity actions and acquisitions. However, rising cost of sales and high debt remain concerns.

Zacks Equity Research

Is Colfax (CFX) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Enersys Gains From Solid Demand & Buyouts Amid Cost Woes

Enersys (ENS) benefits from strength in its transportation business, solid demand for NexSys TPPL products and buyout of Alpha Technologies. However, rising cost of sales and high debt remain concerns.

Zacks Equity Research

Colfax (CFX) Down 55.3% Since Last Earnings Report: Can It Rebound?

Colfax (CFX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Kennametal (KMT) Declines 39% YTD: What's Hurting the Stock?

Kennametal (KMT), with a 39% decline in shares so far in 2020, faces headwinds from difficult end-market conditions, issues with 737 MAX and higher taxes.

Zacks Equity Research

Should Value Investors Pick Colfax (CFX) Stock Right Now?

Is Colfax (CFX) a great pick from the value investor's perspective right now? Read on to know more.

Zacks Equity Research

4 Reasons Why You Should Avoid IDEX (IEX) Stock for Now

IDEX (IEX) is exposed to challenging end markets, unfavorable movements in foreign currencies, and the impacts of variable compensation, tax rate and growth investments.